Evofem Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Update
Evofem Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Update -- Net Revenues Increased 550% Compared to 2020 Fourth Quarter -- -- Over 5,000 Healthcare Providers have Prescribed Phexxi to Date -- -- Management to Host Conference Call Today, Thursday, May 6, 2021, at 4:30 p.m. ET -- News provided by Share this article Share this article SAN DIEGO, May 6, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), today reported financial results for the three-month period ended March 31, 2021. First quarter and recent highlights...
Source: prnewswire.com